Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The D-alanyl-D-alanine peptide terminus is a carboxy-terminal dipeptide motif found at the end of the stem pentapeptide in peptidoglycan precursors of bacterial cell walls. It is a key structural element essential for peptidoglycan cross-linking during bacterial cell wall biosynthesis. This motif acts as a substrate for transpeptidase enzymes (penicillin-binding proteins) and is the principal binding site for clinically important antibiotic classes such as vancomycin, which binds the terminus and sterically blocks cell wall cross-linking, and β-lactam antibiotics, which target the transpeptidase active site. Modifications of this terminus, such as substitution with D-alanyl-D-lactate, confer high resistance to glycopeptide antibiotics. The D-Ala-D-Ala terminus therefore remains a validated antimicrobial drug target and has no mammalian equivalent, making it highly specific for selective disruption of bacterial pathogens[1][4][6][8].
Vancomycin: Binds directly to the D-Ala-D-Ala terminus, blocking access by transpeptidases and inhibiting cell wall synthesis[1][6]. β-lactam antibiotics (including penicillin): Inhibit penicillin-binding proteins that use the D-Ala-D-Ala motif as a substrate, preventing cross-linking of peptidoglycan strands critical for bacterial cell wall integrity[1][4].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on D-alanyl-D-alanine peptide terminus (D-Ala-D-Ala).